BioTech/Drugs - New Brunswick, NJ, US
Replication Medical develops and sells medical devices based on a novel hydrogel platform technology for degenerative conditions in spine, orthopedics, and neuro surgeries. It sells GelStix Nucleus Augmentation implant in Europe for treating lower back pain associated with degenerative disc disease and is currently planning the US FDA clinical trial of GelStix for approval to sell GelStix in the US. IN the US it also sells EnGuard Vessel Guard, a protective cover for spinal blood vessels in anterior fusion and total disc procedures, and GelFix Interspinous Spacer in Europe, a one piece posterior spinal distraction implant. Replication Medical has hired new management and is accelerating GelStix sales commercialization in Europe and planning the GelStix's US clinical trial for approval in the US.
PHP 5.3
Outlook
Microsoft Office 365